Align Technology (ALGN) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary
8 Jun, 2026Business outlook and market dynamics
Guidance range of 5%-15% growth is based on under-penetrated global markets and increased doctor training and product utilization.
International markets, now 55% of business, and U.S. dental service organizations are both growing at double-digit rates.
North America retail segment remains sluggish, but long-term growth prospects remain positive due to product and capability expansion.
Recent quarters have shown 6%-8% growth, with ongoing efforts to sustain and improve this trajectory.
Product innovation and technology
Recent technology day highlighted new and upcoming products, including comprehensive aligner options with and without refinements.
Direct fabricated products offer design flexibility, customization, and improved manufacturing efficiency.
New retainers and aligners with direct fabrication are being tested, aiming to scale up productivity and utilization.
Expansion of digital restorative technology (exocad ART/Invisalign Art) targets the large global base of general dentists.
Geographic and segment performance
International growth is robust, with local teams and infrastructure in key markets like China supporting double-digit expansion.
U.S. dental service organizations continue to outperform retail, driven by digital workflows and patient financing options.
Consumer sentiment in North America remains weak, but education and financing initiatives are helping drive patient conversion.
Latest events from Align Technology
- International growth, product innovation, and integration drive conversion and margin gains.ALGN
Jefferies Global Healthcare Conference 20264 Jun 2026 - AI-powered digital workflows and 3D printing are transforming orthodontic care and patient engagement.ALGN
46th Annual William Blair Growth Stock Conference3 Jun 2026 - Innovation, international growth, and DSOs drive performance amid prudent financial guidance.ALGN
Stifel Jaws & Paws Conference 20262 Jun 2026 - Q1 2026 revenue up 6.2% to $1.04B, with record aligner volumes and $113M net income.ALGN
Q1 20266 May 2026 - Voting standard for Proposal 4 clarified; majority approval of shares present or represented required.ALGN
Proxy filing17 Apr 2026 - Record Q4 and FY2025 revenues, strong Clear Aligner and DSO growth, and positive 2026 outlook.ALGN
Q4 202517 Apr 2026 - Record revenues, robust governance, and enhanced shareholder rights highlight this year's proxy.ALGN
Proxy filing7 Apr 2026 - Virtual Annual Meeting to address director elections, compensation, auditor, and bylaw proposals.ALGN
Proxy filing7 Apr 2026 - Record revenues, robust governance, and enhanced shareholder rights highlight this year's proxy.ALGN
Proxy filing27 Mar 2026